BRAF and melanoma: Rapid EGFR feedback activation has been established as one of the mechanisms of intrinsic resistance to BRAFi in BRAFV600E CRC, which does not occur in BRAFV600E melanoma and explains the sensitivity of the latest to BRAF inhibitors in the clinic [7, 8].